Your session is about to expire
← Back to Search
Autologous stem cell transplant for Mantle Cell Lymphoma
Study Summary
This trial is testing a new combination of drugs to see if it is more effective than the standard treatment for leukemia.
- Mantle Cell Lymphoma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 2 trial • 30 Patients • NCT01182415Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Bendamustine, Rituximab, Cytarabine
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What other research has been conducted on Autologous stem cell transplantation?
"Currently, 750 clinical trials are underway researching Autologous stem cell transplant. Of those studies in progress, 176 have reached Phase 3 status and are disseminated across 26656 sites - the majority of which reside in Bethesda, Maryland."
What diseases has Autologous stem cell transplant proven beneficial in managing?
"Autologous stem cell transplant has been used to treat a variety of illnesses, including contagions and hematological malignancies like dlbcl, meningeal leukemia, or mobilization of hematopoietic cells."
To what extent is Autologous stem cell transplant potentially hazardous to individuals?
"Our team at Power has rated Autologous stem cell transplant a 1 on the safety scale due to its Phase 1 trial status, indicating minimal prior data supporting both efficacy and protection."
In what magnitude is the pool of participants enrolled in this clinical experiment?
"This study has already closed for recruitment; the initial posting date was April 18th 2016 and the last update came on May 23rd 2022. For those searching additional clinical trials, there are currently 1721 open studies concerning lymphoma and 750 medical studies regarding autologous stem cell transplantation that are still admitting patients."
Is there an opportunity to take part in this medical research?
"This experiment seeks 18 individuals ranging from majority age to 65, all of whom possess lymphoma. All candidates must additionally meet the following requirements: Eighteen years old or older and not beyond their sixty-fifth birthday; An ECOG performance status no more than 2; Platelet count at least one hundred thousand/mcl unless otherwise deemed by the attending physician as a consequence of splenomegaly or bone marrow infiltration."
Are there any recruitment opportunities available for this trial?
"Clinicaltrials.gov does not list this medical trial as actively enrolling participants at the present moment, despite its posting on April 18th 2016 and last update of May 23rd 2022. However, there are 2,471 other trials that remain open for patient recruitment."
Does this research initiative admit elderly participants?
"This trial is limited to those aged 18-65. However, there are 478 other clinical trials for minors and 2160 studies available for older individuals."
Share this study with friends
Copy Link
Messenger